Squar Milner Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Squar Milner Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-10	Closed	-$2K	–	711
2020 Q1	$2K	Hold	10	–	–	﹤0.01%	692
2019 Q4	$2K	Buy	+10	New	+$2.02K	﹤0.01%	765
2019 Q3	–	Sell	-15	Closed	-$3K	–	706
2019 Q2	$3K	Hold	15	–	–	﹤0.01%	695
2019 Q1	$2K	Hold	15	–	–	﹤0.01%	785
2018 Q4	$2K	Hold	15	–	–	﹤0.01%	699
2018 Q3	$3K	Hold	15	–	–	﹤0.01%	702
2018 Q2	$3K	Buy	+15	New	+$2.33K	﹤0.01%	796

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Squar Milner Financial Services's VRTX Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Vertex Pharmaceuticals (VRTX) in Q2 2020, closing a stake of 10 shares — an estimated $2K sold.

Squar Milner Financial Services first reported a position in VRTX in Q2 2018 and held it in 7 quarters. The position peaked at $3K in Q2 2019. 964 funds tracked by Wall St. Rank hold VRTX as of Q2 2020.

Squar Milner Financial Services reported no remaining Vertex Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Squar Milner Financial Services sold 10 Vertex Pharmaceuticals shares in Q2 2020, an estimated $2K.
Squar Milner Financial Services first reported a position in Vertex Pharmaceuticals in Q2 2018 and held it in 7 quarters.
Squar Milner Financial Services's Vertex Pharmaceuticals position peaked at $3K in Q2 2019.
964 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.